METHOTREXATE Side Effects

6863343-8 | Condition Aggravated
on Jul 20, 2010 Male patient from , child 5 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated. Methotrexate dosage: . During the same period patient was treated with VINCRISTINE (1.2 Mg) (View Vincristine Review and Vincristine Label ).

6847801-8 | Accidental Exposure, Mouth Ulceration, Neutropenia, Skin Cancer
Patient was taking Methotrexate (View Usage). Patient had the following side effects: accidental exposure, mouth ulceration, neutropenia, skin cancer (What is skin cancer?) on Jun 29, 2010 from UNITED STATES Additional patient health information: Female patient , 48 years of age, . Methotrexate dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ).

6843692-X | Arrhythmia, Interstitial Lung Disease, Metabolic Acidosis, Renal Failure
Adverse event was reported on Jun 30, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: 25 Mg Milligram(s)) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 61 years of age, After Methotrexate was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), interstitial lung disease, metabolic acidosis, renal failure. During the same period patient was treated with (ETANERCEPT) (25 Mg, Miligram(s), 2 Week, Injection) (View (etanercept) Review and (etanercept) Label ).

6840343-5 | Abasia, Bone Pain, Migraine
on Jul 13, 2010 Female patient from UNITED STATES , weighting 190.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, bone pain, migraine (What is migraine?). Methotrexate dosage: 10 Mg 1 A Week Po.


6836221-8 |
on Jul 13, 2010 Female patient from UNITED STATES , weighting 19.29 lb, was treated with Methotrexate (View Usage). . Methotrexate dosage: 3.04 Mg. During the same period patient was treated with VINCRISTINE SULFATE (1.52 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), CISPLATIN (2606 Mg) (View Cisplatin Review and Cisplatin Label ), CYCLOPHOSPHAMIDE (90 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), ETOPOSIDE (57 Mg) (View Etoposide Review and Etoposide Label ).

6830861-8 | Acute Respiratory Distress Syndrome, Bronchiolitis
Patient was taking Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: acute respiratory distress syndrome, bronchiolitis on Jul 09, 2010 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Methotrexate dosage: 20 Mg Qweek Im. During the same period patient was treated with ADALIMUMAB (40 Mg Other Sq) (View Adalimumab Review and Adalimumab Label ). Patient was hospitalized.

6822901-7 | Agitation, Endotracheal Intubation, Grand Mal Convulsion, Headache, Mechanical Ventilation, Renal Impairment, Respiratory Failure, Restlessness, Reversible Posterior Leukoencephalopathy Syndrome
Adverse event was reported on Jun 30, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: 12 Mg On Day 1) was diagnosed with acute lymphocytic leukaemia, tumour lysis syndrome and. Location: POLAND , child 4 years of age, Patient experienced the following unwanted or unexpected effects: agitation, endotracheal intubation, grand mal convulsion, headache (What is headache?), mechanical ventilation, renal impairment, respiratory failure, restlessness, reversible posterior leukoencephalopathy syndrome. During the same period patient was treated with PREDNISONE (NGX) (60 Mg/m2, On Day 1) (View Prednisone (ngx) Review and Prednisone (ngx) Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), SODIUM BICARBONATE (3 1/m2/d) (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), DEXTROSE (Unk) (View Dextrose Review and Dextrose Label ). Patient was hospitalized.

6822858-9 | Acute Hepatic Failure, Acute Respiratory Distress Syndrome, Aspergillosis, Blastomycosis, Encephalopathy, Histoplasmosis Disseminated, Shock
on Jul 07, 2010 Female patient from UNITED STATES , 40 years of age, was diagnosed with psoriatic arthropathy and was treated with Methotrexate (View Usage). Patient had the following side effects: acute hepatic failure, acute respiratory distress syndrome, aspergillosis, blastomycosis, encephalopathy, histoplasmosis disseminated, shock. Methotrexate dosage: . During the same period patient was treated with ENBREL (View Enbrel Review and Enbrel Label ), HUMIRA (View Humira Review and Humira Label ), CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), PLAVIX (View Plavix Review and Plavix Label ), DOCUSATE (View Docusate Review and Docusate Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

6822143-5 | Abdominal Pain, Alanine Aminotransferase Increased, Ascites, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Creatinine Increased, Blood Urea Increased, Hepatomegaly, Liver Tenderness
on Jul 06, 2010 Male patient from UNITED STATES , weighting 168.0 lb, was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, blood urea increased, hepatomegaly, liver tenderness. Methotrexate dosage: 20 Mg. During the same period patient was treated with SICROLIMUS (View Sicrolimus Review and Sicrolimus Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ). Patient was hospitalized.

6822015-6 | Mucosal Inflammation, Pharyngeal Oedema, Swollen Tongue, Therapeutic Agent Toxicity
Patient was taking Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: mucosal inflammation, pharyngeal oedema, swollen tongue, therapeutic agent toxicity on Jul 07, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 222.7 lb, . Methotrexate dosage: 1650 Mg. During the same period patient was treated with PEG L ASPARAGINASE (K H) (11000 Mg) (View Peg-l Asparaginase (k-h) Review and Peg-l Asparaginase (k-h) Label ), VINCRISTINE SULFATE (10 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ). Patient was hospitalized.

6821990-3 | Body Temperature Increased, Cerebral Infarction, Hemiparesis, Nausea, Photophobia, Therapeutic Agent Toxicity
Adverse event was reported on Jul 07, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: 45 Mg) . Location: UNITED STATES , weighting 124.8 lb, Patient had the following side effects: body temperature increased, cerebral infarction, hemiparesis, nausea (What is nausea?), photophobia, therapeutic agent toxicity. During the same period patient was treated with THIOGUANINE (1400 Mg) (View Thioguanine Review and Thioguanine Label ), VINCRISTINE SULFATE (10 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), CYCLOPHOSPHAMIDE (1620 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (976 Mg) (View Cytarabine Review and Cytarabine Label ), DEXAMETHASONE ACETATE (224 Mg) (View Dexamethasone Acetate Review and Dexamethasone Acetate Label ), DOXORUBICIN HYDROCHLORIDE (123 Mg) (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ). Patient was hospitalized.

6820248-6 | Palpitations, Ventricular Extrasystoles
on Jun 29, 2010 Female patient from UNITED KINGDOM , 62 years of age, weighting 224.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), prophylaxis and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: palpitations, ventricular extrasystoles. Methotrexate dosage: 10 Mg, Qw. During the same period patient was treated with FOLIC ACID (5 Mg, Qw) (View Folic Acid Review and Folic Acid Label ), IBUPROFEN (400 Mg, Bid) (View Ibuprofen Review and Ibuprofen Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ).

6816288-3 | No Adverse Event
on Jun 24, 2010 Female patient from UNITED STATES , 47 years of age, was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event. Methotrexate dosage: 0.8ml Subuctaneous Once Weekly.

6815210-3 | Fatigue, Rash Maculo-papular
Patient was taking Methotrexate (View Usage). Patient had the following side effects: fatigue, rash maculo-papular on Jun 30, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 151.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Methotrexate dosage: 10 Mg Qweek Po.

6811818-X | Dyspnoea
Adverse event was reported on Jun 17, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: 50 Mg Milligram(s)) . Location: UNITED KINGDOM , 68 years of age, After Methotrexate was administered, patient had the following side effects: dyspnoea. Patient was hospitalized.

6810470-7 | Cardio-respiratory Arrest, Dyspnoea, Mucosal Erosion, Pancytopenia
on Jun 24, 2010 Female patient from , 76 years of age, was diagnosed with arthropathy, arthralgia and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, dyspnoea, mucosal erosion, pancytopenia. Methotrexate dosage: . During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), TELMISARTAN (80 Mg) (View Telmisartan Review and Telmisartan Label ), HYDROCHLOROTHIAZIDE (25 Mg) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ). Patient was hospitalized.

6810448-3 | Leukopenia, Ovarian Cyst, Septic Shock, Uterine Perforation
on Jun 16, 2010 Female patient from SWITZERLAND , 25 years of age, was diagnosed with choriocarcinoma and was treated with Methotrexate (View Usage). Patient had the following side effects: leukopenia, ovarian cyst (What is ovarian cyst?), septic shock, uterine perforation. Methotrexate dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DACTINOMYCIN (View Dactinomycin Review and Dactinomycin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

6810447-1 | Leukopenia, Ovarian Cyst, Septic Shock, Uterine Perforation
Patient was taking Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: leukopenia, ovarian cyst (What is ovarian cyst?), septic shock, uterine perforation on Jun 16, 2010 from SWITZERLAND Additional patient health information: Female patient , 25 years of age, was diagnosed with choriocarcinoma and. Methotrexate dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DACTINOMYCIN (View Dactinomycin Review and Dactinomycin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

6809832-3 | Metastasis
Adverse event was reported on Jun 28, 2010 by a Male patient taking Methotrexate (View Usage) (Dosage: ) was diagnosed with plasmacytosis and. Location: UNITED KINGDOM , 77 years of age, Patient experienced the following unwanted or unexpected effects: metastasis. During the same period patient was treated with BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ).

6807069-5 | Aphasia, Asthenia, Convulsion, Hemiparesis, Incontinence, Mental Status Changes
on Jun 28, 2010 Male patient from UNITED STATES , weighting 262.4 lb, was treated with Methotrexate (View Usage). Patient had the following side effects: aphasia (What is aphasia?), asthenia, convulsion, hemiparesis, incontinence, mental status changes. Methotrexate dosage: 30 Mg. During the same period patient was treated with CYCLOPHOSPHAMIDE (2200 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), CYTARABINE (825 Mg) (View Cytarabine Review and Cytarabine Label ), MERCAPTOPURINE (1200 Mg) (View Mercaptopurine Review and Mercaptopurine Label ). Patient was hospitalized.

6806548-4 | Bacterial Pyelonephritis, Enterococcal Infection, Hydronephrosis
on Jun 28, 2010 Male patient from UNITED STATES , weighting 175.0 lb, was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: bacterial pyelonephritis, enterococcal infection, hydronephrosis. Methotrexate dosage: . During the same period patient was treated with VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6798040-0 | Cerebral Aspergillosis, Coma, Hypotension, Lung Consolidation, Pneumonia, Septic Embolus, Tachycardia, Thrombocytopenia
Patient was taking Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral aspergillosis, coma, hypotension, lung consolidation, pneumonia (What is pneumonia?), septic embolus, tachycardia, thrombocytopenia on Jun 16, 2010 from UNITED STATES Additional patient health information: Female patient , 53 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Methotrexate dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ).

6795782-8 | Abnormal Behaviour, Agitation, Grand Mal Convulsion, Headache, Mechanical Ventilation, Renal Impairment, Respiratory Failure, Reversible Posterior Leukoencephalopathy Syndrome, Visual Impairment
Adverse event was reported on Jun 16, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: 12 Mg On Day 1) was diagnosed with acute lymphocytic leukaemia and. Location: POLAND , child 4 years of age, Patient had the following side effects: abnormal behaviour, agitation, grand mal convulsion, headache (What is headache?), mechanical ventilation, renal impairment, respiratory failure, reversible posterior leukoencephalopathy syndrome, visual impairment. During the same period patient was treated with PREDNISONE (NGX) (60 Mg/m2, On Day 1) (View Prednisone (ngx) Review and Prednisone (ngx) Label ). Patient was hospitalized.

6784334-1 | Cervical Dysplasia
on Jun 14, 2010 Female patient from BRAZIL , 30 years of age, weighting 124.8 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: cervical dysplasia. Methotrexate dosage: . During the same period patient was treated with CP 690,550 (TASOCITINIB) (View Cp-690,550 (tasocitinib) Review and Cp-690,550 (tasocitinib) Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), LEVONORGESTREL AND ETHINYL ESTRADIOL (View Levonorgestrel And Ethinyl Estradiol Review and Levonorgestrel And Ethinyl Estradiol Label ).

6781727-3 | Anorectal Disorder, Bone Marrow Failure, Clostridium Test Positive, Hypophagia, Pancreatitis, Stomatitis, Vaginal Lesion
on Jun 18, 2010 Female patient from UNITED STATES , weighting 43.43 lb, was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: anorectal disorder, bone marrow failure, clostridium test positive, hypophagia, pancreatitis, stomatitis, vaginal lesion. Methotrexate dosage: 324 Mg. During the same period patient was treated with VINCRISTINE SULFATE (5.5 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), ATOVAQUONE (View Atovaquone Review and Atovaquone Label ), ATROPINE (View Atropine Review and Atropine Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CHLORHEXIDINE (View Chlorhexidine Review and Chlorhexidine Label ). Patient was hospitalized.

6779483-8 | Deafness, Tinnitus
Patient was taking Methotrexate (View Usage). Patient had the following side effects: deafness, tinnitus (What is tinnitus?) on Jun 10, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 64 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), nausea (What is nausea?) and. Methotrexate dosage: 10 Mg, Unk. During the same period patient was treated with FOLIC ACID (5 Mg, Unk) (View Folic Acid Review and Folic Acid Label ), METOCLOPRAMIDE (10 Mg, Unk) (View Metoclopramide Review and Metoclopramide Label ).

6776796-0 | Pulmonary Toxicity, Renal Failure, Shock
Adverse event was reported on Jun 17, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: ) . Location: UNITED STATES , 47 years of age, weighting 163.8 lb, After Methotrexate was administered, patient had the following side effects: pulmonary toxicity, renal failure, shock. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), PROTONIX (View Protonix Review and Protonix Label ), SOLU CORTEF (View Solu-cortef Review and Solu-cortef Label ), LEVOPHED (View Levophed Review and Levophed Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), PLAVIX (View Plavix Review and Plavix Label ).

6776423-2 | Epstein-barr Virus Antibody Positive, Tongue Ulceration
on Jun 01, 2010 Male patient from UNITED KINGDOM , 80 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: epstein-barr virus antibody positive, tongue ulceration. Methotrexate dosage: .

6775392-9 | Epstein-barr Virus Test Positive, Lymphoproliferative Disorder
on Jun 14, 2010 Female patient from , 72 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). Patient had the following side effects: epstein-barr virus test positive, lymphoproliferative disorder. Methotrexate dosage: . During the same period patient was treated with ANTI TNF ALPHA (View Anti-tnf Alpha Review and Anti-tnf Alpha Label ).

6775390-5 | Lymphoproliferative Disorder
Patient was taking Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: lymphoproliferative disorder on Jun 14, 2010 from Additional patient health information: Female patient , 49 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Methotrexate dosage: .

6775230-4 | Anaemia, Decreased Appetite, Dehydration, Haematemesis, Hyperbilirubinaemia, Hyperglycaemia, Mucosal Inflammation, Oropharyngeal Pain, Pyrexia
Adverse event was reported on Jun 15, 2010 by a Male patient taking Methotrexate (View Usage) (Dosage: 225 Mg) . Location: UNITED STATES , weighting 95.02 lb, Patient experienced the following unwanted or unexpected effects: anaemia, decreased appetite, dehydration, haematemesis, hyperbilirubinaemia, hyperglycaemia, mucosal inflammation, oropharyngeal pain, pyrexia. During the same period patient was treated with PEG L ASPARAGINASE (PEGASPARGASE, ONCOSPAR) (6600 Iu) (View Peg-l Asparaginase (pegaspargase, Oncospar) Review and Peg-l Asparaginase (pegaspargase, Oncospar) Label ). Patient was hospitalized.

6774560-X | Epstein-barr Virus Test Positive, Lymphoproliferative Disorder
on Jun 14, 2010 Female patient from , 68 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), lymphoproliferative disorder and was treated with Methotrexate (View Usage). Patient had the following side effects: epstein-barr virus test positive, lymphoproliferative disorder. Methotrexate dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), PIRARUBICIN (View Pirarubicin Review and Pirarubicin Label ).

6772965-4 | Epstein-barr Virus Infection, Lymphoproliferative Disorder
on Jun 14, 2010 Female patient from , 75 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), lymphoproliferative disorder and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: epstein-barr virus infection, lymphoproliferative disorder. Methotrexate dosage: . During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6772802-8 | Bone Marrow Failure, Neutropenic Sepsis, Renal Failure Acute
Patient was taking Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, neutropenic sepsis, renal failure acute on Jun 08, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 83 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), osteoporosis prophylaxis, hypertension and. Methotrexate dosage: 15 Mg, Qw. During the same period patient was treated with ALENDRONIC ACID (70 Mg, Qw) (View Alendronic Acid Review and Alendronic Acid Label ), MELOXICAM (15 Mg, Qd) (View Meloxicam Review and Meloxicam Label ), RAMIPRIL (5 Mg, Qd) (View Ramipril Review and Ramipril Label ).

6771031-1 | Cervix Carcinoma
Adverse event was reported on Jun 08, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: BRAZIL , 30 years of age, weighting 124.8 lb, Patient had the following side effects: cervix carcinoma. During the same period patient was treated with CP 690,550 (TASOCITINIB) (View Cp-690,550 (tasocitinib) Review and Cp-690,550 (tasocitinib) Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), LEVONORGESTREL AND ETHINYL ESTRADIOL (View Levonorgestrel And Ethinyl Estradiol Review and Levonorgestrel And Ethinyl Estradiol Label ).

6768223-4 | Cardiomegaly, Electrocardiogram Repolarisation Abnormality, Pleuropericarditis
on Jun 03, 2010 Male patient from , 57 years of age, was diagnosed with psoriasis and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: cardiomegaly, electrocardiogram repolarisation abnormality, pleuropericarditis. Methotrexate dosage: 7.5mg Per Week/ Orally/ 1 Month.

6768182-4 | Immunosuppression, Large Intestinal Ulcer
on Jun 01, 2010 Female patient from UNITED KINGDOM , 69 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: immunosuppression, large intestinal ulcer. Methotrexate dosage: .

6768170-8 | Mucocutaneous Ulceration
Patient was taking Methotrexate (View Usage). Patient had the following side effects: mucocutaneous ulceration on Jun 01, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 80 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Methotrexate dosage: .

6768169-1 | Epstein-barr Virus Infection, Immunosuppression, Mouth Ulceration
Adverse event was reported on Jun 01, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 60 years of age, After Methotrexate was administered, patient had the following side effects: epstein-barr virus infection, immunosuppression, mouth ulceration.

6767929-0 | Hepatosplenomegaly, Lymphoproliferative Disorder
on Jun 04, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: hepatosplenomegaly, lymphoproliferative disorder. Methotrexate dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6767635-2 | Amnesia, Anxiety, Condition Aggravated, Confusional State, Depression, Dyskinesia, Extrapyramidal Disorder, Headache
on May 27, 2010 Female patient from UNITED KINGDOM , 72 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Methotrexate (View Usage). Patient had the following side effects: amnesia, anxiety (What is anxiety?), condition aggravated, confusional state, depression (What is depression?), dyskinesia, extrapyramidal disorder, headache (What is headache?). Methotrexate dosage: Im. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized and became disabled.

6765173-4 | Dyspnoea, Mental Status Changes, Tachycardia, Wound Infection
Patient was taking Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: dyspnoea, mental status changes, tachycardia, wound infection on Jun 10, 2010 from UNITED STATES Additional patient health information: Male patient , 75 years of age, . Methotrexate dosage: Every 2 Weeks For 3 Cycles. During the same period patient was treated with VINBLASTINE SULFATE (Every 2 Weeks For 3 Cycles) (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), DOXORUBICIN HCL (Every 2 Weeks For 3 Cycles) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), CISPLATIN (Every 2 Weeks For 3 Cycles) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

6764431-7 | Oral Disorder
Adverse event was reported on May 27, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: ) . Location: FRANCE , 15 years of age, Patient experienced the following unwanted or unexpected effects: oral disorder. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), LYSANXIA (View Lysanxia Review and Lysanxia Label ), TERCIAN (View Tercian Review and Tercian Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PURINETHOL (View Purinethol Review and Purinethol Label ). Patient was hospitalized.

6764413-5 | Hepatic Enzyme Increased
on May 27, 2010 Female patient from FRANCE , 15 years of age, was diagnosed with bone sarcoma and was treated with Methotrexate (View Usage). Patient had the following side effects: hepatic enzyme increased. Methotrexate dosage: .

6759587-6 | Squamous Cell Carcinoma
on May 25, 2010 Male patient from UNITED KINGDOM , 77 years of age, was diagnosed with plasmacytosis and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: squamous cell carcinoma. Methotrexate dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ).

6759586-4 | Pleural Effusion, Pleuropericarditis
Patient was taking Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: pleural effusion, pleuropericarditis on May 25, 2010 from ITALY Additional patient health information: Male patient , 57 years of age, was diagnosed with psoriasis and. Methotrexate dosage: 7.5 Mg/week. During the same period patient was treated with FOLINIC ACID (5 Mg/week) (View Folinic Acid Review and Folinic Acid Label ).

6759046-0 | Amnesia, Anxiety, Condition Aggravated, Confusional State, Depression, Dyskinesia, Extrapyramidal Disorder, Headache
Adverse event was reported on May 28, 2010 by a Female patient taking Methotrexate (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 72 years of age, Patient had the following side effects: amnesia, anxiety (What is anxiety?), condition aggravated, confusional state, depression (What is depression?), dyskinesia, extrapyramidal disorder, headache (What is headache?). During the same period patient was treated with ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ). Patient was hospitalized and became disabled.

6758835-6 | Anaemia, Arteriovenous Fistula, Fanconi Syndrome, Glycosuria, Haematuria, Haemodialysis, Hypokalaemia, Hypomagnesaemia, Proteinuria
on May 31, 2010 Female patient from POLAND , child 11 years of age, was diagnosed with osteosarcoma metastatic and was treated with Methotrexate (View Usage). After Methotrexate was administered, patient had the following side effects: anaemia, arteriovenous fistula, fanconi syndrome, glycosuria, haematuria, haemodialysis, hypokalaemia, hypomagnesaemia, proteinuria. Methotrexate dosage: Unk. During the same period patient was treated with ETOPOSIDE (Unk) (View Etoposide Review and Etoposide Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ).

6756127-2 | Decreased Appetite, Diarrhoea, Hepatic Enzyme Increased, Hypokalaemia, Hyponatraemia, Mouth Ulceration, Nausea
on Jun 03, 2010 Male patient from UNITED STATES , 62 years of age, weighting 163.1 lb, was treated with Methotrexate (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, diarrhoea, hepatic enzyme increased, hypokalaemia, hyponatraemia, mouth ulceration, nausea (What is nausea?). Methotrexate dosage: 15,280 Mg Once Iv.

6755517-1 | Clostridium Difficile Colitis, Dehydration, Eczema Asteatotic, Mucosal Inflammation, Pancytopenia
Patient was taking Methotrexate (View Usage). Patient had the following side effects: clostridium difficile colitis, dehydration, eczema asteatotic, mucosal inflammation, pancytopenia on Feb 24, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 66 years of age, was diagnosed with metastases to meninges and. Methotrexate dosage: 12.5 Mg Milligram(s), 1 Week, Intrathecal. During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), IBANDRONIC ACID (View Ibandronic Acid Review and Ibandronic Acid Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), QUININE (View Quinine Review and Quinine Label ), TINZAPARIN (View Tinzaparin Review and Tinzaparin Label ).